Major Pharmaceuticals Recalls Levothyroxine Sodium Tablets Over Subpotency
Major Pharmaceuticals is voluntarily recalling Levothyroxine Sodium Tablets, 75 mcg, NDC 0904-6951-61, due to subpotency. The recall affects lots N02172, N02296, and N02288 with expiration dates in July and December 2026, distributed nationwide.
- Product
- LEVOTHYROXINE SODIUM — LEVOTHYROXINE SODIUM (LEVOTHYROXINE SODIUM)
- Category
- Drug
- Distribution
- Distributed nationwide